SCHEMBL9709737

SCHEMBL9709737

Cc1cc(Cl)c2ncccc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.50
MAPT P10636 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.44
CCR1 P32246 3/20 0.44
CCR8 P51685 3/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 5/20 0.43
TOP1 P11387 1/20 0.41
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSP90AA1 P07900 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALOX15B O15296 1/20 0.40
NR1I2 O75469 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31373510 0.81 CCR1 (0.47) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL829514 0.81 CCR1 (0.47) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL8284604 0.81 PRMT5 (0.68) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL6637754 0.78 PRMT5 (0.59) PRMT5CCR1CCR8LMNAALDH1A1
SCHEMBL14649499 0.78 KDM4E (0.47) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL20468597 0.78 PRMT5 (0.50) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL6636369 0.78 PRMT5 (0.50) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL9710251 0.77 PRMT5 (0.46) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL28133510 0.77 PRMT5 (0.42) PRMT5MAPTL3MBTL1CCR1CCR8
SCHEMBL14666994 0.75 PRMT5 (0.47) PRMT5MAPTL3MBTL1CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992022533-A1 4-AMINOQUINOLINES AND PHARMACEUTICAL COMPOSITIONS THEREOF THE UPJOHN COMPANY (US) 1992-12-23 WO disclosed